NAR(SZ:002825)2022-04-25 16:00Revenue and Profit - Revenue for Q1 2022 reached ¥506,509,460.47, an increase of 37.85% compared to ¥367,430,228.28 in the same period last year[3] - Net profit attributable to shareholders was ¥22,756,955.95, up 6.47% from ¥21,374,376.69 year-on-year[3] - Net profit excluding non-recurring items increased by 31.21% to ¥26,078,784.52 from ¥19,874,915.21 in the previous year[3] - The total operating revenue for Q1 2022 was RMB 506,509,460.47, compared to RMB 367,430,228.28 in the previous period, indicating a significant increase[16] - The net profit for Q1 2022 was RMB 36,195,574.58, slightly down from RMB 36,665,686.09 in the previous period[16] - The net profit for Q1 2022 was CNY 29,966,030.62, compared to CNY 32,910,012.67 in Q1 2021, indicating a decrease of about 8.9%[18] - The company reported a decrease in net profit attributable to minority shareholders, which was CNY 7,209,074.67 in Q1 2022, down from CNY 11,535,635.98 in Q1 2021, a decline of approximately 37.5%[18] Cash Flow and Assets - Operating cash flow decreased by 56.40% to ¥5,796,039.69 from ¥13,293,785.18 in the same period last year[3] - Cash and cash equivalents at the end of Q1 2022 were RMB 490,894,999.63, a decrease from RMB 519,619,528.23 at the beginning of the year[13] - The net cash flow from operating activities was CNY 5,796,039.69, down from CNY 13,293,785.18 in the previous year, a decline of approximately 56.4%[20] - The cash and cash equivalents at the end of Q1 2022 were CNY 413,777,641.70, compared to CNY 246,900,129.67 at the end of Q1 2021, showing an increase of about 67.5%[22] - Total assets at the end of the period were ¥1,747,735,339.69, a slight increase of 0.18% from ¥1,744,552,847.92 at the end of the previous year[3] - Total assets as of March 31, 2022, were RMB 1,747,735,339.69, slightly up from RMB 1,744,552,847.92 at the beginning of the year[15] Liabilities and Equity - Total liabilities decreased to ¥572,607,624.04 from ¥599,368,074.40, indicating a reduction of approximately 4.5%[15] - The company's equity attributable to shareholders increased to RMB 1,077,662,190.91 from RMB 1,054,928,323.46, reflecting a growth of about 2.1%[15] Research and Development - Research and development expenses rose by 41.09% to ¥22,696,995.58, reflecting increased investment in new product development[7] - Research and development expenses for Q1 2022 were RMB 22,696,995.58, compared to RMB 16,086,872.98 in the previous period, showing an increase of approximately 41.3%[16] Investments and Subsidies - The company reported a significant increase in long-term equity investments, which rose by 99.63% to ¥27,423,877.04 due to new investments[7] - The company received government subsidies amounting to ¥592,826.56, an increase of 281.14% compared to the previous year[7] Future Plans - The company plans to continue expanding its market presence and investing in new technologies[3] Earnings Per Share - The basic earnings per share remained stable at CNY 0.13 for both Q1 2022 and Q1 2021[18] Financial Reporting - The company did not report any audited financial results for Q1 2022[23]